Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Phone408-345-8886
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$4.91 billion
Profitability
Miscellaneous
Employees14,800
OptionableOptionable
Agilent Technologies (NYSE:A) Frequently Asked Questions
What is Agilent Technologies' stock symbol?
Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."
How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?
Agilent Technologies announced a quarterly dividend on Wednesday, November 14th. Stockholders of record on Monday, December 31st will be paid a dividend of $0.164 per share on Wednesday, January 23rd. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Friday, December 28th. This is an increase from Agilent Technologies's previous quarterly dividend of $0.15. View Agilent Technologies' Dividend History.
How will Agilent Technologies' stock buyback program work?
Agilent Technologies declared that its board has initiated a share repurchase plan on Monday, November 19th 2018, which allows the company to buyback $1,750,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 8.8% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's board believes its shares are undervalued.
How were Agilent Technologies' earnings last quarter?
Agilent Technologies Inc (NYSE:A) announced its quarterly earnings data on Wednesday, February, 20th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.73 by $0.03. The medical research company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. Agilent Technologies had a net margin of 6.43% and a return on equity of 19.84%. The firm's quarterly revenue was up 6.0% on a year-over-year basis. During the same period last year, the business posted $0.66 EPS. View Agilent Technologies' Earnings History.
What guidance has Agilent Technologies issued on next quarter's earnings?
Agilent Technologies updated its FY19 earnings guidance on Wednesday, February, 20th. The company provided earnings per share guidance of $3.03-3.07 for the period, compared to the Thomson Reuters consensus estimate of $3.04. The company issued revenue guidance of $5.15-5.19 billion, compared to the consensus revenue estimate of $5.17 billion.Agilent Technologies also updated its FY 2019 guidance to $3.03-3.07 EPS.
What price target have analysts set for A?
8 brokers have issued 1 year target prices for Agilent Technologies' stock. Their forecasts range from $77.00 to $89.00. On average, they expect Agilent Technologies' share price to reach $83.00 in the next year. This suggests a possible upside of 5.7% from the stock's current price. View Analyst Price Targets for Agilent Technologies.
What is the consensus analysts' recommendation for Agilent Technologies?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.
Has Agilent Technologies been receiving favorable news coverage?
News stories about A stock have been trending somewhat positive this week, InfoTrie reports. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Agilent Technologies earned a coverage optimism score of 1.7 on InfoTrie's scale. They also assigned media headlines about the medical research company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the immediate future.
Who are some of Agilent Technologies' key competitors?
Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).
Who are Agilent Technologies' key executives?
Agilent Technologies' management team includes the folowing people:
- Mr. Michael R. McMullen, CEO, Pres & Director (Age 58)
- Mr. Robert W. McMahon, Sr. VP & CFO (Age 50)
- Mr. Dominique P. Grau, Sr. VP of HR (Age 60)
- Mr. Mark Doak, Sr. VP (Age 64)
- Mr. Jacob Thaysen, Sr. VP (Age 44)
Who are Agilent Technologies' major shareholders?
Agilent Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.84%), Geode Capital Management LLC (1.33%), Northern Trust Corp (1.20%), Findlay Park Partners LLP (1.15%), Cantillon Capital Management LLC (1.12%) and D. E. Shaw & Co. Inc. (1.10%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.
Which major investors are selling Agilent Technologies stock?
A stock was sold by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., BlackRock Inc., Millennium Management LLC, MERIAN GLOBAL INVESTORS UK Ltd, Canada Pension Plan Investment Board, State of Tennessee Treasury Department, Orbimed Advisors LLC and Bank of New York Mellon Corp. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Dominique Grau, Heidi Fields, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.
Which major investors are buying Agilent Technologies stock?
A stock was bought by a variety of institutional investors in the last quarter, including Findlay Park Partners LLP, Oregon Public Employees Retirement Fund, Pendal Group Ltd, Two Sigma Advisers LP, Geode Capital Management LLC, Bank of Nova Scotia, Mackay Shields LLC and Thrivent Financial for Lutherans. View Insider Buying and Selling for Agilent Technologies.
How do I buy shares of Agilent Technologies?
Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Agilent Technologies' stock price today?
One share of A stock can currently be purchased for approximately $78.56.
How big of a company is Agilent Technologies?
Agilent Technologies has a market capitalization of $24.95 billion and generates $4.91 billion in revenue each year. The medical research company earns $316 million in net income (profit) each year or $2.79 on an earnings per share basis. Agilent Technologies employs 14,800 workers across the globe.
What is Agilent Technologies' official website?
How can I contact Agilent Technologies?
Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]
MarketBeat Community Rating for Agilent Technologies (NYSE A)
MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days.
